IQVIA Q1 2026: Record Revenue, AI Growth

IQVIAs Q1 2026 earnings shatter records with revenue surging 8.4% and adjusted EPS up 7.4% YoY. Organic growth in Commercial and R&D Solutions doubled and tripled, respectively. A record backlog of $34.2B, with $8.9B converting to revenue in the next year. AI agents adoption soared, with 19 of the top 20 pharma giants using IQVIAs services. Financials remain robust, with adjusted EBITDA up 5.5% and adjusted EPS raised to $12.65-$12.95. Q2 revenue projected at $4.28-$4.34B, maintaining momentum in life sciences. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/e2b28e9e74ae5cb5